| Bioactivity | CB2 receptor agonist 9 (Compound 33) is an orally active agonist for cannabinoid receptor 2 (CB2 receptor) with an EC50 of 16.2 nM. CB2 receptor agonist 9 inhibits the expression of TNF-α, IL-1β and IL-6, exhibits anti-inflammatory efficacy in DDS (HY-116282)-induced mouse acute colitis model[1]. |
| CAS | 2374894-21-8 |
| Formula | C16H23N3O2S |
| Molar Mass | 321.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jiang BE, et al., Design, synthesis, and biological evaluations of 5-aryl-pyrazole-3-carboxamide derivatives as selective CB2 receptor agonists for the treatment of colitis. Eur J Med Chem. 2024 Dec 2;283:117117. |
CB2 receptor agonist 9
CAS: 2374894-21-8 F: C16H23N3O2S W: 321.44
CB2 receptor agonist 9 (Compound 33) is an orally active agonist for cannabinoid receptor 2 (CB2 receptor) with an EC50
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.